Physician profile
Daniel L Boss
NPI 1417959123
$667.67
in general payments reported to CMS, 2019-2025
15 companies · $170 in 2025
The $170 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.90 · 2020: $12.47 · 2021: $160 · 2022: $48.25 · 2023: $167 · 2024: $73.21 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $410.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $159.47 | 2020-2025 | Wegovy, Saxenda, Ozempic |
| Abbvie INC. | $104.80 | 2023-2025 | Qulipta, Ubrelvy |
| Pfizer INC. | $87.75 | 2021-2025 | |
| Lilly USA, LLC | $56.71 | 2023-2025 | Mounjaro, Zepbound |
| Janssen Pharmaceuticals, INC | $45.65 | 2019-2021 | |
| Stryker Corporation | $40.88 | 2024 | Accolade |
| Astrazeneca Pharmaceuticals LP | $24.74 | 2025 | Breztri |
| Sanofi Pasteur INC. | $21.56 | 2019 | |
| Dexcom, INC. | $20.45 | 2025 | Dexcom G6 Transmitter |
| Vital Connect, INC | $20.12 | 2023 | Vitalpatch Rtm |
| Boston Scientific Corporation | $19.37 | 2023 | Bodyguardian |
| Exact Sciences Corporation | $18.19 | 2023 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $17.77 | 2022 | |
| Organogenesis INC. | $15.36 | 2021 | |
| Abbott Laboratories | $14.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Boss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.